Cellosaurus cell line 520C9 (CVCL

Cellosaurus 520C9 (CVCL_G612)

Cross-references
Cell line name	520C9
Synonyms	520C9.C3B10T; 520 C9
Accession	CVCL_G612
Resource Identification Initiative	To cite this cell line use: 520C9 (RRID:CVCL_G612)
Comments	Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8696. Monoclonal antibody isotype: IgG1. Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_2199 (Sp2/0-Ag14)
Category	Hybridoma
Web pages	Info; -; -; https://www.law.uh.edu/faculty/gvetter3/fcplc/CaseFiles/2004/PDF/Chiron%20Corp.%20v.%20Genentech,%20Inc.,%2003-1158%20(Fed.%20Cir.%20Mar.%2030,%202004).pdf
Publications	Patent=US4753894 Frankel A.E., Ring D.B., Bjorn M.J. Monoclonal anti-human breast cancer antibodies. Patent number US4753894, 28-Jun-1988 PubMed=2470501 Ring D.B., Kassel J.A., Hsieh-Ma S.T., Bjorn M.J., Tringale F., Eaton A.M., Reid S.A., Frankel A.E., Nadji M. Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancer. Cancer Res. 49:3070-3080(1989) Patent=US4938948 Ring D.B., Frankel A.E. Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies. Patent number US4938948, 03-Jul-1990 PubMed=1715033; DOI=10.1016/0161-5890(91)90056-p Ring D.B., Clark R., Saxena A. Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal antibodies with recombinant c-erbB-2. Mol. Immunol. 28:915-917(1991) Patent=US5169774 Frankel A.E., Ring D.B., Laird W.J. Monoclonal anti-human breast cancer antibodies. Patent number US5169774, 08-Dec-1992
Cell line collections (Providers)	ATCC; HB-8696
Cell line databases/resources	CLO; CLO_0001408
Encyclopedic resources	Wikidata; Q54603715
Entry history
Entry creation	11-Feb-2013
Last entry update	10-Apr-2025
Version number	8